Walder Wyss’ IP team successfully represented the pharmaceutical company Merck in appeal proceedings before the Swiss Federal Supreme Court against its US competitor MSD. The case Following World War I, Merck’s US subsidiary, which
Tags :Ex-Featured
Nater Dallafior‘s expert on IP/IT and media Mathis Berger (pictured) advised the German Football League (DFL Deutsche Fussball Liga) on all Swiss law aspects of the sale of television rights for the German
Santhera Pharmaceuticals Holding announced the closing of the first tranche of its financing arrangement with a fund managed by Highbridge Capital Management. The team was led by partner Matthias Courvoisier (Capital Markets) and senior associate
The team was led by partner Stefan Knobloch (Corporate/M&A - pictured) and managing associate Fabienne Anner (Corporate/M&A)
The team consisted of partner Matthias Courvoisier, senior associate Yves Mauchle and trainee Jan Lusti
The sale process was initiated by Bridgepoint in early November 2019 but was delayed due to Covid-19 pandemic. Partners Group's general counsel Andreas Knecht (pictured) worked in this transaction.
The team was led by partner Jürg Luginbühl (Corporate/M&A - pictured) and included associate Christian Gutzwiller (Corporate/M&A), senior associate Elias Mühlemann (TMT) and associate Michel Stübi (Corporate/
Schellenberg Wittmer is acting as legal counsel to the sellers, whereas Loyens & Loeff advised Cellularline on all Swiss legal aspects of the transaction.
The team was led by partner Daniel Hasler (Corporate/ M&A - pictured) and included partners Jürg Frick (Banking & Finance), Reto Heuberger (Tax)
The team included partner Thomas Bähler, counsel Kathrin Enderli, lawyer Michèle Remund.
